Immuneering Corporation (IMRX) is experiencing a notable decline in its stock price, down 11.37% to $1.94 as of 1:08 pm on October 14, after opening at $2.17. The stock has reached a high of $2.20 and a low of $1.94 today, with a volume of 605,815 shares traded, which is only 9.61% of its average daily volume of 6,306,257. The decline follows concerns highlighted in a recent analysis about the company's cash burn situation. Immuneering's cash burn rate has increased by 6.2% over the past year, with a cash runway of approximately 14 months as of June 2024. The company's cash burn of $51 million is significant relative to its market capitalization of $65 million, raising concerns about the need for additional funding.